Werlinich Asset Management’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,638
Closed -$112K 58
2023
Q1
$112K Sell
1,638
-23
-1% -$1.79K 0.1% 55
2022
Q4
$101K Sell
1,661
-43
-3% -$4K 0.09% 56
2022
Q3
$171K Sell
1,704
-34
-2% -$3.96K 0.18% 55
2022
Q2
$153K Sell
1,738
-183
-10% -$22.4K 0.14% 55
2022
Q1
$292K Buy
1,921
+60
+3% +$11.2K 0.22% 54
2021
Q4
$593K Buy
+1,861
New +$656K 0.43% 52

Other funds holding RBOT

Werlinich Asset Management's RBOT Position: Q2 2023 in Review

Werlinich Asset Management sold out of Vicarious Surgical (RBOT) in Q2 2023, closing a stake of 1,638 shares — an estimated $112K sold.

Werlinich Asset Management first reported a position in RBOT in Q4 2021 and held it in 6 quarters. The position peaked at $593K in Q4 2021. 74 funds tracked by Wall St. Rank hold RBOT as of Q2 2023.

  • Werlinich Asset Management reported no remaining Vicarious Surgical position as of Q2 2023 after selling out during the quarter.
  • Werlinich Asset Management sold 1,638 Vicarious Surgical shares in Q2 2023, an estimated $112K.
  • Werlinich Asset Management first reported a position in Vicarious Surgical in Q4 2021 and held it in 6 quarters.
  • Werlinich Asset Management's Vicarious Surgical position peaked at $593K in Q4 2021.
  • 74 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2023.

Based on Werlinich Asset Management's 13F filing for Q2 2023, filed 13 Nov 2023.